A carregar...
Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation
Enhancer of zeste homolog 2 (EZH2), which is overexpressed in a wide range of tumors, contributes to ovarian cancer malignancy in several different ways. We aimed to illustrate the role of EZH2 in ovarian cancer cisplatin resistance and to identify possible underlying mechanisms of this role that ma...
Na minha lista:
| Publicado no: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5989839/ https://ncbi.nlm.nih.gov/pubmed/29630768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13599 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|